183 related articles for article (PubMed ID: 10329411)
1. Cell-lysate conversion of prion protein into its protease-resistant isoform suggests the participation of a cellular chaperone.
Saborío GP; Soto C; Kascsak RJ; Levy E; Kascsak R; Harris DA; Frangione B
Biochem Biophys Res Commun; 1999 May; 258(2):470-5. PubMed ID: 10329411
[TBL] [Abstract][Full Text] [Related]
2. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier.
Kocisko DA; Priola SA; Raymond GJ; Chesebro B; Lansbury PT; Caughey B
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3923-7. PubMed ID: 7732006
[TBL] [Abstract][Full Text] [Related]
3. Prion protein conversion in vitro.
Supattapone S
J Mol Med (Berl); 2004 Jun; 82(6):348-56. PubMed ID: 15014886
[TBL] [Abstract][Full Text] [Related]
4. Cell-free formation of protease-resistant prion protein.
Kocisko DA; Come JH; Priola SA; Chesebro B; Raymond GJ; Lansbury PT; Caughey B
Nature; 1994 Aug; 370(6489):471-4. PubMed ID: 7913989
[TBL] [Abstract][Full Text] [Related]
5. Chaperone-supervised conversion of prion protein to its protease-resistant form.
DebBurman SK; Raymond GJ; Caughey B; Lindquist S
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13938-43. PubMed ID: 9391131
[TBL] [Abstract][Full Text] [Related]
6. A receptor for infectious and cellular prion protein.
Martins VR
Braz J Med Biol Res; 1999 Jul; 32(7):853-9. PubMed ID: 10454744
[TBL] [Abstract][Full Text] [Related]
7. Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform.
Kaneko K; Peretz D; Pan KM; Blochberger TC; Wille H; Gabizon R; Griffith OH; Cohen FE; Baldwin MA; Prusiner SB
Proc Natl Acad Sci U S A; 1995 Nov; 92(24):11160-4. PubMed ID: 7479957
[TBL] [Abstract][Full Text] [Related]
8. Aggregates of scrapie-associated prion protein induce the cell-free conversion of protease-sensitive prion protein to the protease-resistant state.
Caughey B; Kocisko DA; Raymond GJ; Lansbury PT
Chem Biol; 1995 Dec; 2(12):807-17. PubMed ID: 8807814
[TBL] [Abstract][Full Text] [Related]
9. Species barrier in prion diseases: a kinetic interpretation based on the conformational adaptation of the prion protein.
Kellershohn N; Laurent M
Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):539-45. PubMed ID: 9729459
[TBL] [Abstract][Full Text] [Related]
10. Cofactor and glycosylation preferences for in vitro prion conversion are predominantly determined by strain conformation.
Burke CM; Walsh DJ; Mark KMK; Deleault NR; Nishina KA; Agrimi U; Di Bari MA; Supattapone S
PLoS Pathog; 2020 Apr; 16(4):e1008495. PubMed ID: 32294141
[TBL] [Abstract][Full Text] [Related]
11. Molecular clues to pathogenesis in prion diseases.
Laurent M; Johannin G
Histol Histopathol; 1997 Apr; 12(2):583-94. PubMed ID: 9151145
[TBL] [Abstract][Full Text] [Related]
12. Properties of the scrapie prion protein: quantitative analysis of protease resistance.
Oesch B; Jensen M; Nilsson P; Fogh J
Biochemistry; 1994 May; 33(19):5926-31. PubMed ID: 7910036
[TBL] [Abstract][Full Text] [Related]
13. A scrapie-like unfolding intermediate of the prion protein domain PrP(121-231) induced by acidic pH.
Hornemann S; Glockshuber R
Proc Natl Acad Sci U S A; 1998 May; 95(11):6010-4. PubMed ID: 9600908
[TBL] [Abstract][Full Text] [Related]
14. Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells.
Bate C; Tayebi M; Diomede L; Salmona M; Williams A
BMC Biol; 2008 Sep; 6():39. PubMed ID: 18789130
[TBL] [Abstract][Full Text] [Related]
15. Molecular properties of complexes formed between the prion protein and synthetic peptides.
Kaneko K; Wille H; Mehlhorn I; Zhang H; Ball H; Cohen FE; Baldwin MA; Prusiner SB
J Mol Biol; 1997 Jul; 270(4):574-86. PubMed ID: 9245588
[TBL] [Abstract][Full Text] [Related]
16. [Unfolding chaperone as a prion protein relating molecule].
Hachiya NS; Sakasegawa Y; Kaneko K
Rinsho Shinkeigaku; 2003 Nov; 43(11):817-9. PubMed ID: 15152473
[TBL] [Abstract][Full Text] [Related]
17. The intriguing prion disorders.
Abid K; Soto C
Cell Mol Life Sci; 2006 Oct; 63(19-20):2342-51. PubMed ID: 16927029
[TBL] [Abstract][Full Text] [Related]
18. Prions at the crossroads: the need to identify the active TSE agent.
Nandi PK
Bioessays; 2004 May; 26(5):469-73. PubMed ID: 15112226
[TBL] [Abstract][Full Text] [Related]
19. Prion encephalopathies of animals and humans.
Prusiner SB
Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
[TBL] [Abstract][Full Text] [Related]
20. Protease resistance of infectious prions is suppressed by removal of a single atom in the cellular prion protein.
Leske H; Hornemann S; Herrmann US; Zhu C; Dametto P; Li B; Laferriere F; Polymenidou M; Pelczar P; Reimann RR; Schwarz P; Rushing EJ; Wüthrich K; Aguzzi A
PLoS One; 2017; 12(2):e0170503. PubMed ID: 28207746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
